Global Smart Insulin Pens and Pumps Market to Reach $8.3 Billion by 2030
The global market for Smart Insulin Pens and Pumps estimated at US$4.4 Billion in the year 2022, is projected to reach a revised size of US$8.3 Billion by 2030, growing at a CAGR of 8.1% over the analysis period 2022-2030. Pumps, one of the segments analyzed in the report, is projected to record 7.4% CAGR and reach US$7.1 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Pens segment is readjusted to a revised 13.1% CAGR for the next 8-year period.The U.S. Market is Estimated at $1.3 Billion, While China is Forecast to Grow at 7.5% CAGR
The Smart Insulin Pens and Pumps market in the U.S. is estimated at US$1.3 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$1.4 Billion by the year 2030 trailing a CAGR of 7.5% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7.3% and 6.2% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 6.2% CAGR.Select Competitors (Total 33 Featured) -
- Cellenovo
- Companion Medical Inc.
- Emperra Gmbh E-Health Technologies
- F Hoffmann-La Roche
- Insulet Corporation
- Jiangasu Delfu Medical Device Co Ltd
- Medical Inc.
- Medtronic Inc.
- Novo Nordisk
- Sooil Development
- Tandem Diabetes Care
- Valeritas Inc.
- Ypsomed
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its 'bumpy' reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERSIII. MARKET ANALYSISIV. COMPETITION
1. MARKET OVERVIEW
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
CANADA
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
ITALY
UNITED KINGDOM
REST OF EUROPE
ASIA-PACIFIC
REST OF WORLD
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Cellenovo
- Companion Medical Inc.
- Emperra Gmbh E-Health Technologies
- F Hoffmann-La Roche
- Insulet Corporation
- Jiangasu Delfu Medical Device Co Ltd
- Medical Inc.
- Medtronic Inc.
- Novo Nordisk
- Sooil Development
- Tandem Diabetes Care
- Valeritas Inc.
- Ypsomed
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 89 |
Published | March 2024 |
Forecast Period | 2022 - 2030 |
Estimated Market Value ( USD | $ 4.4 Billion |
Forecasted Market Value ( USD | $ 8.3 Billion |
Compound Annual Growth Rate | 8.3% |
Regions Covered | Global |